Fluticasone propionate aqueous nasal spray in pregnancy rhinitis

Clinical Otolaryngology and Allied Sciences

Volumn 26, Issue 5, 2001, Pages 394-400

  Ellegård, Eva K ^a   Hellgren, M ^b   Karlsson, N G ^b,c  

^a Kungsbacka Hospital   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Corticosteroid; Fiuticasone; Pregnancy rhinitis; Propionate; Treatment

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FETUS GROWTH; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MOTHER FETUS RELATIONSHIP; NOSE CONGESTION; PEAK EXPIRATORY FLOW; PREGNANCY COMPLICATION; PREGNANCY RHINITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOMETRY; SYMPTOM; ULTRASOUND;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PROBABILITY; REFERENCE VALUES; RHINITIS; TREATMENT OUTCOME;

EID: 0034771681     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2001.00491.x     Document Type: Article

References (41)

1. Irritation of the sexual apparatus as an etiological factor in the production of nasal disease
2. Incidence of vasomotor rhinitis during pregnancy
3. The relation of nasal to sexual function
4. Rhinitis of pregnancy
5. Managing pregnancy-related nocturnal nasal congestion. The external nasal dilator
6. Intranasal steroid injection during pregnancy
7. The human respiratory nasal mucosa in pregnancy
8. Nasal congestion during pregnancy
9. The incidence of pregnancy rhinitis
10. Serum level of placental growth hormone is raised in pregnancy rhinitis
11. IgE-mediated reactions and hyperreactivity in pregnancy rhinitis
12. Measuring health-related quality of life in rhinitis
13. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus
14. The management of nasal obstruction during pregnancy
15. Rhinitis during pregnancy and rhinitis medicamentosa
16. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride and placebo nasal sprays
17. Mometasone furoate. A review of its intranasal use in allergic rhinitis
18. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis
19. Glucocorticoid featment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment
20. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa
21. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: Efficacy in allergic and non-allergic perennial rhinitis
22. Intranasal fluticasone propionate; a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis
23. Pharmacokinetics and bioavailability of intranasal fluticasone in humans
24. Nasal congestion during the menstrual cycle
25. Assessing degree of nasal patency by measuring peak expiratory flow rate through the nose
26. Efficacy of a saccharin test for screening to detect abnormal mucociliary clearance
27. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline
28. Four-week use of oxymetazoline nasal spray (Nezeril®) once daily at night induces rebound swelling and nasal hyperreactivity
29. The pathophysiology and treatment of rhinitis medicamentosa
30. Treatment with xylometazoline (Otrivin®) nose drops over a six-week period
31. Rhinitis during pregnancy
32. Acoustic rhinometry: Values from adults with subjective normal nasal patency
33. Acoustic rhinometry used as a method to monitor the effect of intramuscular injection of steroid in the treatment of nasal polyps
34. Intranasal steroids and septum perforation - An overlooked complication? A description of the course of events and a discussion of the causes
35. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity
36. 24 Hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids
37. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticoids
38. Beclomethasone dipropionate aerosol effect on the adrenals in normal persons
39. Systemic effects of two nasally administered glucocorticoids
40. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis
41. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis